Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies

FHS
March 18, 2024
11:08 am

Immunome signs deal to use Arrayjet platform in its in-house screening operations.

Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally | Psychedelic Invest

Enveric Biosciences (NASDAQ: ENVB) (“Enveric”), a biotechnology company dedicated to the development of novel neuroplastogens for the treatment of neuropsychiatric disorders, today announced encouraging EB-003 preclinical

July 25, 2024

A type of intermittent fasting reduces fluctuations in blood sugar levels

Early-time restricted feeding, a type of intermittent fasting, improved fluctuations in blood glucose levels and decreased time above range, according to research being presented Thursday

June 15, 2023

MarketingRx roundup: Eli Lilly’s marketing chief at Cannes Lions, Biogen raises more Alzheimer’s awareness

Eli Lilly’s chief corporate brand officer, Lina Polemini, joined two other marketing leaders at Cannes Lions on Monday to talk about what it means to

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.